CAP-ACP Workload Model for Advanced Diagnostics in Precision Medicine.

Advanced diagnostics Biomarker testing Next-generation sequencing Oncology Precision medicine Workload

Journal

American journal of clinical pathology
ISSN: 1943-7722
Titre abrégé: Am J Clin Pathol
Pays: England
ID NLM: 0370470

Informations de publication

Date de publication:
01 07 2022
Historique:
received: 07 09 2021
accepted: 14 01 2022
pubmed: 24 2 2022
medline: 6 7 2022
entrez: 23 2 2022
Statut: ppublish

Résumé

In precision medicine, where oncologic management is tailored to the individual's clinical and genetic profiles, advanced diagnostic testing provides prognostic information and guides management in a growing number of malignancies. There is a need to capture the work pathologists perform to meet this demand by providing medically relevant, timely, and accurate testing results. This work includes not only direct patient consults (interpretation of results and issuing reports) but the administrative and medical oversight as well as the research needed to provide the necessary quality assurance, quality control, direction, and framework for the laboratory. An expert panel of Canadian pathologists involved in advanced diagnostics was convened to establish and beta test a model for workload assessment in advanced diagnostics. All aspects of the advanced diagnostics workload were detailed and applied to models based on members' experience, including medical oversight, administration, and the introduction of new testing and platforms. Models for biomarker testing were developed for simple and complex or multiplexed assays, and a detailed model was developed to assess the workload for next-generation sequencing-based assays. This paper provides the first detailed proposal for capturing an advanced diagnostic workload to enable appropriate pathologist allotment for performing all the steps required to run an advanced diagnostic service.

Identifiants

pubmed: 35195689
pii: 6534988
doi: 10.1093/ajcp/aqac012
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105-111

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of American Society for Clinical Pathology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Paul C Park (PC)

Shared Health Manitoba, Winnipeg, Canada.

Kyle C Kurek (KC)

Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Canada.

John DeCoteau (J)

Department of Pathology and Laboratory Medicine, University of Saskatchewan, Saskatoon, Canada.

Christopher J Howlett (CJ)

Department of Pathology and Laboratory Medicine, London Health Sciences Centre and Western University, London, Canada.

Cynthia Hawkins (C)

The Hospital for Sick Children, Toronto, Canada.

Iyare Izevbaye (I)

Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.

Michael D Carter (MD)

Nova Scotia Health, Central Zone, Halifax, Canada.

Margaret Redpath (M)

Department of Pathology, McGill University, Montréal, Canada.

Bryan Lo (B)

The Ottawa General Hospital, Ottawa, Canada.

Deepu Alex (D)

BC Cancer, Vancouver, Canada.

George Yousef (G)

The Hospital for Sick Children, Toronto, Canada.

Stephen Yip (S)

BC Cancer, Vancouver, Canada.

Raymond Maung (R)

Royal Inland Hospital, Kamloops, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH